BHC

Bausch Health

• Dow Jones·10/30 15:15

  Bausch Health Shares Climb on 3Q Profit, Revenue Rise

• Dow Jones·10/29 20:14

  *Bausch 3Q >BHC

• Dow Jones·10/29 20:14

  *Bausch 3Q Rev $2.68B >BHC

• Dow Jones·10/29 20:14

  *Bausch Raises FY25 View To Rev $10.05B-$10.25B >BHC

• Dow Jones·10/29 11:25

  Bausch + Lomb Swings to Quarterly Loss, Though Revenue Rises

• Dow Jones·10/09 12:15

  Bausch Health Shareholders Approve Adoption of Poison Pill Plan

• The Wall Street Journal·09/21 09:30

  How the FDA Is Taking Aim at the Surreal World of TV Drug Ads

• Dow Jones·09/11 21:08

  *News On Durect Corp. (DRRX) Now Under BHC.T

• Dow Jones·08/15 19:06

  Carl Icahn's Son, Icahn Capital Portfolio Manager Exit Bausch Health Board

• Dow Jones·08/15 18:32

  *Bausch Health: Icahn Group Net Long Position Fell Below Specified Threshold >BHC

• Dow Jones·08/15 18:32

  *Bausch Health: Director Appointment and Nomination Agreement With Icahn Group Terminated Pursuant to Terms >BHC

• Dow Jones·08/15 18:31

  *Bausch Health: Brett M. Icahn, Steven D. Miller Resign From Board

• Dow Jones·07/30 20:15

  *Bausch Health Sees FY Rev $10B-$10.25B >BHC

• Dow Jones·07/30 20:14

  *Bausch Health 2Q Rev $2.53B >BHC

• Dow Jones·07/29 14:15

  Durect Shares Soar With Takeover Offer From Bausch Health